SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041051
Filing Date
2019-11-06
Accepted
2019-11-06 16:21:26
Documents
50
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abio-10q_20190930.htm 10-Q 1492546
2 EX-10.1 abio-ex101_11.htm EX-10.1 23442
3 EX-31.1 abio-ex311_8.htm EX-31.1 8585
4 EX-31.2 abio-ex312_6.htm EX-31.2 8543
5 EX-32.1 abio-ex321_7.htm EX-32.1 11195
  Complete submission text file 0001564590-19-041051.txt   3914750

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abio-20190930.xml EX-101.INS 545491
7 XBRL TAXONOMY EXTENSION SCHEMA abio-20190930.xsd EX-101.SCH 33096
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20190930_cal.xml EX-101.CAL 26663
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20190930_def.xml EX-101.DEF 96703
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20190930_lab.xml EX-101.LAB 291152
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20190930_pre.xml EX-101.PRE 200756
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 191196596
SIC: 2835 In Vitro & In Vivo Diagnostic Substances